Three prominent investment firms bet changes are in the offing at ailing healthcare giant CVS Health and added to existing ...

Third Point took new stakes in Tesla (NASDAQ:TSLA), with 400K shares, CVS Health (NYSE:CVS), with 1.58M shares, and ...

CV Sciences Q3 2024 financial results: stable $3.9M revenue, improved 46% gross margin, new products, and nearing cash flow break-even.

Charles Rhyee, an analyst from TD Cowen, maintained the Buy rating on CVS Health (CVS – Research Report). The associated price target was ...